Twitter LinkedIn
    Saturday, July 2
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»Biopharma company Alvotech to go public in $2.25 bln SPAC deal
    Deals & Transactions

    Biopharma company Alvotech to go public in $2.25 bln SPAC deal

    December 7, 2021Updated:December 7, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Biopharmaceutical company Alvotech Holdings SA said on Tuesday it plans to list in New York by merging with a blank-check company backed by Oaktree Capital Management, in a deal that values the combined entity at around $2.25 billion.

    The Iceland-based company will receive gross proceeds of $450 million from the deal, including $150 million from a private placement in public equity backed by Temasek, CVC Capital Partners and funds managed by Suvretta Capital among others.

    Oaktree Acquisition Corp II, a special purpose acquisition company (SPAC), raised $225 million through an initial public offering (IPO) in September last year.

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    deals PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Carlyle hires BlackRock’s McNeely to work with biggest clients

    July 1, 2022

    Permira considers sale of Funds Platform Alter Domus

    July 1, 2022

    Riveron, an H.I.G. Capital Portfolio Company, acquires Clermont Partners

    July 1, 2022

    ARCH Venture Partners closes $2.975bn Fund XII

    July 1, 2022

    Comments are closed.

    Other Articles

    Software firm SpotOn valued at $3.6bn after Dragoneer-led funding round

    May 23, 2022

    Sunlight Financial LLC to List on NYSE Through Apollo-Affiliated Spartan Acquisition Corp. II Merger

    January 26, 2021

    Private Equity Faces Funding Squeeze, Baring PE Founder Says

    April 5, 2022

    Humatica advises Intermediate Capital Group (ICG) on investment in Lucid Group

    March 19, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?